Crispr Therapeutics shares owned by Mirador Capital Partners
Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by Mirador Capital Partners
from 13F filings
Historical chart of Mirador Capital Partners investment in Crispr Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Crispr Therapeutics held by Mirador Capital Partners consolidated in one spreadsheet with up to 7 years of data
Download as csv Download as ExcelQuarterly reported holdings in Crispr Therapeutics by Mirador Capital Partners
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-03-31 | $203k | 3.0k | 68.16 |
2022-12-31 | $201k | 4.9k | 40.65 |
2022-09-30 | $292k | 4.5k | 65.28 |
2022-06-30 | $256k | 4.2k | 60.79 |
2022-03-31 | $261k | 4.2k | 62.79 |
2021-12-31 | $319k | 4.2k | 75.75 |